Search Results - "Pilancı, K N"

Effectiveness and safety of cabazitaxel chemotherapy for metastatic castration-resistant prostatic carcinoma on Turkish patients (The Anatolian Society of Medical Oncology) by Süner, A, Aydın, D, Hacıoğlu, M B, Doğu, G G, İmamoğlu, G I, Menekşe, S, Pilancı, K N, Yazıcı, Ö K, Koca, D, Karaağaç, M, Akyol, M, Akman, T, Ergen, S, Avcı, N, Kaçan, T, Bozkurt, O, Kefeli, U, Urakçı, Z, Araz, M, Arpacı, E, Harputlu, H, Sevinç, A

“…Prostate cancer is among the most common cancers in males. Prostate cancer is androgen dependent in the beginning, but as time progresses, it becomes…”
Get more information

Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes by Esin, Ece, Oksuzoglu, B., Bilici, A., Cicin, I., Kostek, O., Kaplan, M. A., Aksoy, S., Aktas, B. Y., Ozdemir, O., Alacacioglu, A., Cabuk, D., Sumbul, A. T., Sakin, A., Paydas, S., Yetisir, E., Er, O., Korkmaz, T., Yildirim, N., Sakalar, T., Demir, H., Artac, M., Karaagac, M., Harputluoglu, H., Bilen, E., Erdur, E., Degirmencioglu, S., Aliyev, A., Cil, T., Olgun, P., Basaran, G., Gumusay, O., Demir, A., Tanrikulu, E., Yumuk, P. F., Imamoglu, Inanc, Oyan, B., Cetin, B., Haksoyler, V., Karadurmus, N., Erturk, I., Evrensel, T., Yilmaz, H., Beypinar, I., Kocer, M., Pilanci, K. N., Seker, M., Urun, Y., Yildirim, N., Eren, T., Demirci, U.

“…Purpose In this study, we aimed to describe the real-life practice outcomes of pertuzumab–trastuzumab–taxane (PTT) combination in visceral organ metastatic,…”
Get full text

254PAnti-mullerian hormone (AMH) levels and antral follicle counts (AFC) may predict ovarian reserves before systemic chemotherapy (SC) in women with breast cancer (BC): A prospective clinical study by Ordu, C, Gachayev, F, Elbuken, F, Baysal, B, Pilanci, K N, Alco, G, Ilgun, A S, Ucuncu, M, Ozturk, A, Erdogan, Z, Agacayak, F, Ozdem, G, Kayan, T, Uyar, T, Hocaoğlu, E, Soybir, G, Aktepe, F, Ozmen, V

“…Abstract Background Systemic chemotherapy (SC) has a negative effect on ovarian functions. The aim of this study is to investigate the effect of SC on…”
Get full text

Abstract P2-12-17: Mini latissimus dorsi flap increases breast conserving surgery rate in early stage breast cancer patients by Ozmen, V, Sarsenov, D, Ozmen, T, Ilgun, S, Alco, G, Ordu, C, Agacayak, F, Elbuken, F, Erdogan, Z, Pilanci, KN

“…Abstract Background Oncoplastic techniques enabled performing breast conserving surgery (BCS) to larger tumors. Mini latissimus dorsi flap (MLDF) is a novel…”
Get full text

Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment? by Pilanci, Kezban Nur, Alco, Gul, Ordu, Cetin, Sarsenov, Dauren, Celebi, Filiz, Erdogan, Zeynep, Agacayak, Filiz, Ilgun, Serkan, Tecimer, Coskun, Demir, Gokhan, Eralp, Yesim, Okkan, Sait, Ozmen, Vahit

“…One of the most important adverse effects of zoledronic acid (ZA) is osteonecrosis of the jaw (ONJ). In previous literature, several risk factors have been…”
Get full text

Is there any effect of lower extremity deep vein thrombosis which proven by Doppler ultrasonography on cancer recurrence in patients with stage III colon cancer? A study of the Turkish Descriptive Oncological Researches Group by Tanriverdi, Ozgur, Yildirim, Birdal, Gul, Suha, Cevik, Esin, Akman, Tulay, Cokmert, Suna, Pilanci, Kezban Nur, Avci, Nilufer, Ordu, Cetin, Barutca, Sabri

“…This study aimed to determine the predictive value of lower extremity deep vein thrombosis (LE-DVT) on first cancer recurrence in patients with stage III colon…”
Get full text